retatrutide safety retatrutide clinical trial A new from Eli Lilly and Company suggests its experimental triple hormone drug, retatrutide, could become one of the next major medications in the rapidly growing weight loss and diabetes retatrutide liver safety Retatrutide: A

Eli Lilly acquired Protomer Technologies in late 2024, a biotech that was working on advanced glucagon like peptide treatments

Potential Variables The effectiveness of compounded semaglutide depends on proper compounding practices

L., Wever, L

In glycemic control trials, adjudicated acute pancreatitis occurred at 0.3 cases per 100 patient-years on treatment versus 0.2 on comparator

Visceral fat is metabolically active tissue that accumulates around your liver, pancreas, and intestines, driving insulin resistance and inflammation far more aggressively than subcutaneous fat under your skin

Gut microbiota, 1013 new pieces in the Parkinsons disease puzzle